Handbook of Targeted Cancer Therapy and Immunotherapy, Second edition
Produs indisponibil momentan. Pentru comenzi va rugam trimiteti mail la adresa depozit2@prior.ro sau contactati-ne la numarul de telefon 021 210 89 28 Vedeti mai jos alte produse similare disponibile.
Disponibilitate: Acest produs nu este momentan in stoc
Editura: LWW
Limba: Engleza
Nr. pagini: 408
Coperta: Softcover
Dimensiuni: 11.43 x 1.78 x 13.72 cm
An aparitie: 2018
Description:
Publisher's Note: Products purchased from 3rd Party sellers are not guaranteed by the Publisher for quality, authenticity, or access to any online entitlements included with the product. A must-have resource for oncologists, researchers, and other cancer care professionals!
Table of Contents:
Section 1 Targets by Organ Site
Abbreviations
Adrenocortical Carcinoma (ACC)—Mouhammed A. Habra, Aung Naing
Biliary Tract Adenocarcinoma (Gallbladder, Bile Duct)—Milind Javle, Ahmed O. Kaseb, Goldy C. George, Kathrina Marcelo-Lewis, David S. Hong
Bladder Carcinoma (Urothelial Cancer)—Arlene O. Siefker-Radtke
Brain Tumors—Vivek Subbiah, Michael Pearlman
Glioblastoma/Malignant Gliomas
Other NF-Related Tumors
Medulloblastoma
Meningiomas
Breast Cancer—Senthil Damodaran, Debu Tripathy
ER/PR+
HER2+
Triple-Negative/Basal
Cervical Cancer—Laura L. Holman, Siqing Fu, Shannon N. Westin
Colorectal Cancer—Allan A. L. Pereira, David S. Hong, Goldy C. George, E. Scott Kopetz
Esophageal Cancer (Squamous Cell)—Mustafa Bozkurt, David S. Hong, Goldy C. George, Mariela B. Murphy
Gastric/Gastroesophageal Junction (Adenocarcinoma)—Mustafa Bozkurt, David S. Hong, Goldy C. George, Mariela Blum Murphy
Head and Neck Cancer—Renata Ferrarotto, Kathrina Marcelo-Lewis, Sarina A. Piha-Paul, Sangeeta Goswami, Erminia Massarelli
Salivary Gland
Squamous Cell
Nasopharynx
Kidney (Renal Cell) Cancer—Vivek Subbiah, Nizar M. Tannir
Leukemia—Prajwal C. Boddu, Radhika Kainthla, Tapan M. Kadia, Naveen Pemmaraju
Acute Myeloid Leukemia (AML)
Acute Lymphoblastic Leukemia (ALL)
Chronic Myeloid Leukemia (CML)
Chronic Lymphocytic Leukemia (CLL)
Myeloproliferative Neoplasm (MPN)
Liver Cancer (Hepatocellular)—Shiraj Sen, Xiaochun Liu, Ahmed O. Kaseb
Lung Cancer—Daniel D. Karp, Kathrina Marcelo-Lewis, Ralph G. Zinner, Lauren Byers
NSCLC
SCLC
Lymphoma— Raphael Steiner, Xiaochun Liu, Jason R. Westin
Multiple Myeloma—Hans C. Lee, Manojkumar Bupathi, Jatin J. Shah, Robert Orlowski
Ovarian Cancer—Laura L. Holman, Siqing Fu, Shannon N. Westin
Pancreatic Cancer (Ductal Carcinoma)—Milind Javle, Kathrina Marcelo-Lewis, Goldy C. George, David S. Hong
Prostate Cancer (Adenocarcinoma)—Paul G. Corn, Kathrina Marcelo-Lewis
Sarcoma (Gastrointestinal Stromal Tumors, GIST)—Jason Roszik, Vivek Subbiah, Anthony Conley
Sarcoma
Skin Cancer—Gerald S. Falchook, Scott. Woodman, Michael K. K. Wong
Melanoma—Meredith A. McKean, Gerald S. Falchook, Hussein Tawbi, Scott E. Woodman
Basal Cell—Gerald S. Falchook, Scott E. Woodman, Michael K. K. Wong
Squamous Cell—Gerald S. Falchook, Scott E. Woodman, Michael K. K. Wong
Merkel Cell—Gerald S. Falchook, Scott E. Woodman, Michael K. K. Wong
Testicular Cancer (Germ Cell Carcinoma)—Vivek Subbiah, Lance C. Pagliaro
Thymus Carcinoma (Thymic and Thymoma)—Gerald S. Falchook, Ralph G. Zinner
Thyroid Cancer—Maria E. Cabanillas, Manojkumar Bupathi
Papillary and Follicular Carcinoma
Papillary, Follicular, and Hurthle Cell Carcinoma
Medullary Carcinoma
Anaplastic Carcinoma
Uterine (Endometrial) Cancer—Laura L. Holman, Siqing Fu, Shannon N. Westin
Section 2 Carcinogenesis from the Perspective of Targeted Therapy and Immunotherapy
Section 3 Molecular Targets and Pathways
Signal Transduction–The Big Picture—Daniel D. Karp
Color Key
Angiogenesis—Kathrina Marcelo-Lewis
Angiogenesis Regulators—Kathrina Marcelo-Lewis
Targeting HIF-1α—Kathrina Marcelo-Lewis180
Receptor Tyrosine Kinases—Kathrina Marcelo-Lewis
VEGFR Signaling and Targeting VEGFR —Kathrina Marcelo-Lewis
FGFR Signaling and Targeting FGFR—Kathrina Marcelo-Lewis
Aberrations in FGFR Associated with Cancer—Kathrina Marcelo-Lewis
Targeting the FGFR Pathway—Kathrina Marcelo-Lewis
PDGFR and Targeting PDGFR—Jennifer Herold, Ecaterina Ileana-Dumbrava
TIE Receptors—Ecaterina Ileana-Dumbrava
IGFR-1 and Insulin Receptor— Ashley Perkins, Ecaterina Ileana-Dumbrava
Targeting IGFR-1 and Insulin Receptor—Ashley Perkins, Ecaterina Ileana-Dumbrava
TGFβ/SMAD Pathway—Ashley Perkins, Ecaterina Ileana-Dumbrava
Targeting TGFβ/SMAD Pathway—Ashley Perkins, Ecaterina Ileana-Dumbrava
EGFR Family of Receptors—Kavitha Balaji
EGFR Signaling in Cancer—Kavitha Balaji
EGFR Alterations—Kavitha Balaji
Targeting EGFR—Kavitha Balaji
HER2—Kavitha Balaji
ERBB2/HER2 Alterations in Cancer—Kavitha Balaji
Targeting HER2—Kavitha Balaji
HGF Receptors: MET—Matthew Reilley
Targeting MET—Matthew Reilley
RET Receptor—Matthew Reilley
ALK Receptor—Matthew Reilley
ALK Alterations—Matthew Reilley
KIT—Jennifer Herold
Targeting KIT—Jennifer Herold
ROS-1 Receptor—Matthew Reilley
Targeting ROS-1—Matthew Reilley
G-Protein–Coupled Receptors—Ed Kheder
RAS/MAPK Pathway—Ed Kheder
MAPK Pathway—Ed Kheder
Targeting RAS—Ed Kheder
Targeting BRAF—Ed Kheder
Targeting MEK—Ed Kheder
PI3K Pathway—Ana Stuckett
PI3K–AKT–mTOR Pathway—Ana Stuckett
Targeting PI3K Mutations—Ana Stuckett
Targeting AKT Mutations—Ana Stuckett
Targeting PTEN and TSC Alterations—Ana Stuckett
Targeting mTORC1 and mTORC2—Ana Stuckett
JAK/STAT Pathway—Le Huang
Targeting JAK—Le Huang
Hedgehog Signaling Pathway—Shhyam Moorthy
NOTCH Pathway—Shhyam Moorthy
Wnt Pathway—Shhyam Moorthy
SRC Pathway—Shhyam Moorthy
NFκb Pathway—Shhyam Moorthy
Death Receptors and Apoptosis—Patrick Pilie
Cell Cycle Regulation—Patrick Pilie
TP53—Patrick Pilie
RB1—Patrick Pilie
CDKN2A—Patrick Pilie
DNA Damage Response—Ecaterina Ileana-Dumbrava
Targeting DNA Damage Response—Ecaterina Ileana-Dumbrava
Aurora Kinases—Ecaterina Ileana-Dumbrava
Immunotherapy—Hossein Maymani
Targeting PD-1 and PD-L1—Hossein Maymani
Immunotherapy—Hossein Maymani
Targeting CTLA-4—Hossein Maymani
Immunotherapy—Hossein Maymani
Management of Immune-Related Diarrhea and Colitis—Kathrina Marcelo-Lewis, Ecaterina Ileana-Dumbrava
Management of Immune-Related Hepatitis—Kathrina Marcelo-Lewis, Ecaterina Ileana-Dumbrava
Management of Immune-Related Pneumonitis—Kathrina Marcelo-Lewis, Ecaterina Ileana-Dumbrava
Management of Immune-Related Nephritis—Kathrina Marcelo-Lewis, Ecaterina Ileana-Dumbrava
Management of Immune-Related Skin Rash/Toxicities—Kathrina Marcelo-Lewis, Ecaterina Ileana-Dumbrava
Management of Immune-Related Peripheral Neurologic Toxicities—Kathrina Marcelo-Lewis, Ecaterina Ileana-Dumbrava
Management of Immune-Related Thyroid Function Adverse Events—Kathrina Marcelo-Lewis, Ecaterina Ileana-Dumbrava
Epigenetics—Le Huang
Targeting Epigenetics in Cancer—Le Huang
Antibody–Drug Conjugates—Roman Groisberg
TRK Signaling Pathway—Sandra Montez
Targeting Cancer Metabolism—Shiraj Sen
Ewing Sarcoma Gene Fusion Partners—Daniel D. Karp
Section 4 Targeted and Immunotherapy Agents
Color Key
Abbreviations
Abiraterone Acetate (Zytiga)
Acalabrutinib (Calquence)
Ado-Trastuzumab Emtansine (Kadcyla)
Afatinib Dimaleate (Gilotrif)
Afuresertib
Alectinib (Alecensa)
Alemtuzumab (Campath-1h)
Alisertib
Alpelisib
Apatinib
Atezolizumab (Tecentriq)
Avelumab (Bavencio)
Axicabtagene Ciloleucel (Yescarta)
Axitinib (Inlyta)
Anetumab Ravtansine
AZD-1775
AZD9150
Belinostat (Beleodaq)
Bevacizumab (Avastin)
BI 811283
Bicalutamide (Casodex/Cosudex)
Binimetinib
Blinatumomab (Blincyto)
BMS-936559
Bortezomib (Velcade)
Bosutinib (Bosulif)
Brentuximab Vedotin (Adcetris)
Brigatinib (Alunbrig)
Brivanib Alaninate
Buparlisib
Cabozantinib (Cometriq)
Carfilzomib (Kyprolis)
Cediranib
Ceritinib (Zykadia)
Cetuximab (Erbitux)
Cixutumumab
Cobimetinib (Cotellic)
Combretastatin Disodium
Copanlisib (Aliqopa)
Crizotinib (Xalkori)
Dabrafenib (Tafinlar)
Dacomitinib
Dactolisib
Daratumumab (Darzalex)
Dasatinib (Sprycel)
Denosumab (Xgeva)
Dovitinib
Durvalumab (Imfinzi)
Elotuzumab (Empliciti)
Enasidenib Mesylate (Idhifa)
Encorafenib
Enzalutamide (Xtandi)
Epratuzumab
Erlotinib (Tarceva)
Everolimus (Afinitor)
Farletuzumab
Figitumumab
Foretinib
Fostamatinib Disodium
Galunisertib
Ganitumab
Gefitinib (Iressa)
Gemtuzumab Ozogamicin (Mylotarg)
Idelalisib (Zydelig)
Ibrutinib (Imbruvica)
Imatinib Mesylate (Gleevec)
INC280
Iniparib
Inotuzumab Ozogamicin
Ipilimumab (Yervoy)
Ivosidenib
Lapatinib Ditosylate (Tykerb)
Lenalidomide (Revlimid)
Lenvatinib Mesylate (Lenvima)
LGK974
Linifanib
Linsitinib
Lonafarnib
LOR-253 HCL
Larotrectinib
LOXO-292
LY2157299
Mocetinostat
Mogamulizumab (Poteligeo)
Masitinib Mesylate
Matuzumab
MEDI0639
Midostaurin (Rydapt)
Mirvetuximab Soravtansine
MK-0752
MK-2206
MK-8242
MKC-1
MSC2156119J
Navitoclax
Necitumumab (Portrazza)
Neratinib (Nerlynx)
Nilotinib (Tasigna)
Nimotuzumab
Nintedanib
Niraparib (Zejula)
Nivolumab (Opdivo)
Obinutuzumab (Gazyva)
Ofatumumab (Arzerra)
Olaparib (Lynparza)
Omipalisib
Olaratumab (Lartruvo)
OMP-54F28
Onartuzumab
Orantinib
Osimertinib (Tagrisso)
Pacritinib
Palbociclib (Ibrance)
Panitumumab (Vectibix)
Panobinostat
Pazopanib Hydrochloride (Votrient)
PEG-interferon alfa-2b (Sylatron)
Pembrolizumab (Keytruda)
Pemetrexed (Alimta)
Perifosine
Pertuzumab (Perjeta)
PF-03814735
Pilaralisib
Pimasertib
Pomalidomide (Pomalyst)
Ponatinib Hydrochloride (Iclusig)
Poziotinib
Pralatrexate (Folotyn)
PRI-724
Quizartinib
Ramucirumab (Cyramza)
Refametinib
Regorafenib (Stivarga)
Reolysin
Ridaforolimus
Rigosertib
Rilotumumab
Rituximab (Rituxan)
Romidepsin (Istodax)
Rovalpituzumab Tesirine
Rucaparib Camsylate (Rubraca)
Ruxolitinib Phosphate (Jakafi)
Salirasib
Saracatinib
Selinexor
Selumetinib
Sipuleucel-T (Provenge)
Sirolimus (Rapamune)
Sonidegib (Odomzo)
Sonolisib
Sorafenib (Nexavar)
Sunitinib (Sutent)
Talimogene Laherparepvec (Imlygic)
Talazoparib
Telatinib
Temsirolimus (Torisel)
Teprotumumab
Tipifarnib
Tisagenlecleucel (Kymriah)
Tivantinib
Trabectidin (Yondelis)
Trabedersen
Trametinib (Mekinist)
Trastuzumab (Herceptin)
Tremelimumab
Triciribine
Trebananib
Trifluridine and Tipiracil (Lonsurf)
Valproic Acid (Depakote)
Vandetanib (Caprelsa)
Vantictumab
Vanucizumab
Veliparib
Vemurafenib (Zelboraf)
Venetoclax (Venclexta)
Vismodegib (Erivedge)
Vocimagene Amiretrorepvec
Vorinostat (Zolinza)
Zalutumumab
Ziv-Aflibercept (Zaltrap)
Index
la
An aparitie | 2018 |
Autor | Daniel D. Karp, Gerald S. Falchook and Joann Lim |
Dimensiuni | 11.43 x 1.78 x 13.72 cm |
Editura | LWW |
Format | Softcover |
ISBN | 9781496389138 |
Limba | Engleza |
Nr pag | 408 |
Clientii ebookshop.ro nu au adaugat inca opinii pentru acest produs. Fii primul care adauga o parere, folosind formularul de mai jos.